Pursuant to Regulation 30 (read with Part A of Schedule III) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, Sequent Scientific has informed that the Board of Directors based on the recommendation of the Nomination and Remuneration Committee held on August 07, 2023, approved the appointment of Dr. Hari Babu Bodepudi (DIN: 01119678) as Additional Director (Non?Executive Non?Independent) with effect from August 07, 2023. Dr. Hari Babu Bodepudi will hold office until the conclusion of the ensuing Annual General Meeting of the Company and the Company will be seeking approval of the shareholders at the ensuing Annual General Meeting. Brief profile and other Information of aforesaid Director pursuant to SEBI Circular bearing reference SEBI/HO/CFD/CFD?PoD?1/P/CIR/2023/123 dated July 13, 2023 is mentioned in ‘Annexure A’ as enclosed.
The above information is a part of company’s filings submitted to BSE.
